Recurrence of venous thromboembolism

Jørn Dalsgaard Nielsen, Erik Lerkevang Grove, Torben Bjerregaard Larsen, Anette Asbjerg Højen

Abstract

Recurrence of venous thromboembolism (VTE) is seen in approximately one third of the patients after discontinuation of therapy with anticoagulants. The duration of treatment seems to be of minor importance, as several studies have shown the same recurrence rate over years after treatment for three months and up to 24 months. In patients with reversible risk factors, three months of treatment seems to be sufficient. Treatment duration should be determined by physicians with special expertise in risk factors for VTE recurrence and bleeding complications.

Bidragets oversatte titelRecurrence of venous thromboembolism
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind180
Udgave nummer20A
ISSN0041-5782
StatusUdgivet - 1 okt. 2018

Emneord

  • Anticoagulants
  • Humans
  • Recurrence
  • Risk Factors
  • Venous Thromboembolism

Fingeraftryk

Dyk ned i forskningsemnerne om 'Recurrence of venous thromboembolism'. Sammen danner de et unikt fingeraftryk.

Citationsformater